Rare diseases
Investigational molecules
Locations
Back to Spain1 657 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
SpainStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
SpainStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
SpainStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
SpainStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
SpainStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
SpainStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
SpainStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
SpainStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
SpainA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
SpainAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
SpainA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.
Studies aim to improve treatment outcomes for patients with complex metabolic conditions.
Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.
Research focuses on developing targeted treatments for various neurological conditions.
Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.
Studies aim to enhance vaccine efficacy and immune response across different age groups.
Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.
Focus on developing innovative approaches to improve cancer treatment outcomes.
Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.
Research aims to develop more effective treatments for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
